Investors typically flee to consumer staples and healthcare stocks during geopolitical turmoil, but this pattern has broken down. While sectors like pharma offer relatively inexpensive valuations compared to their growth, these defensive plays aren't providing the usual safe harbor. In 2022, Russia's invasion of Ukraine sent investors rushing toward consumer staples and healthcare as inflation surged.

This time is different. Market volatility has left investors searching for stability, yet traditional defensive sectors haven't delivered the expected protection. The pharma sector, despite having many stocks trading at attractive multiples relative to growth, hasn't attracted the usual flight-to-quality capital. This divergence from historical patterns suggests changing investor sentiment or perhaps deeper market concerns.

What makes this particularly notable is the contrast with previous crises. When geopolitical shocks rattled markets in the past, defensive sectors reliably outperformed. Now, even as investors worry about global instability, they're not finding comfort in the usual safe havens. This shift could signal broader market dynamics at play, from changing sector fundamentals to evolving investor priorities.